346 related articles for article (PubMed ID: 23879434)
41. Gut microbiota changes and chronic hepatitis C virus infection.
Preveden T; Scarpellini E; Milić N; Luzza F; Abenavoli L
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):813-819. PubMed ID: 28621554
[TBL] [Abstract][Full Text] [Related]
42. Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?
Rasaratnam B; Connelly N; Chin-Dusting J
Clin Sci (Lond); 2004 Nov; 107(5):425-34. PubMed ID: 15270715
[TBL] [Abstract][Full Text] [Related]
43. Intestinal permeability is increased in patients with advanced cirrhosis.
Pascual S; Such J; Esteban A; Zapater P; Casellas JA; Aparicio JR; Girona E; Gutiérrez A; Carnices F; Palazón JM; Sola-Vera J; Pérez-Mateo M
Hepatogastroenterology; 2003; 50(53):1482-6. PubMed ID: 14571769
[TBL] [Abstract][Full Text] [Related]
44. Intestinal dysfunction in liver cirrhosis: Its role in spontaneous bacterial peritonitis.
Ramachandran A; Balasubramanian KA
J Gastroenterol Hepatol; 2001 Jun; 16(6):607-12. PubMed ID: 11422611
[TBL] [Abstract][Full Text] [Related]
45. Evidence for intestinal oxidative stress in obstructive jaundice-induced gut barrier dysfunction in rats.
Assimakopoulos SF; Vagianos CE; Patsoukis N; Georgiou C; Nikolopoulou V; Scopa CD
Acta Physiol Scand; 2004 Feb; 180(2):177-85. PubMed ID: 14738476
[TBL] [Abstract][Full Text] [Related]
46. Impaired intestinal immunity and barrier function: a cause for enhanced bacterial translocation in alcohol intoxication and burn injury.
Choudhry MA; Rana SN; Kavanaugh MJ; Kovacs EJ; Gamelli RL; Sayeed MM
Alcohol; 2004 Jul; 33(3):199-208. PubMed ID: 15596088
[TBL] [Abstract][Full Text] [Related]
47. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
Chopyk DM; Grakoui A
Gastroenterology; 2020 Sep; 159(3):849-863. PubMed ID: 32569766
[TBL] [Abstract][Full Text] [Related]
48. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function.
Du Plessis J; Vanheel H; Janssen CE; Roos L; Slavik T; Stivaktas PI; Nieuwoudt M; van Wyk SG; Vieira W; Pretorius E; Beukes M; Farré R; Tack J; Laleman W; Fevery J; Nevens F; Roskams T; Van der Merwe SW
J Hepatol; 2013 Jun; 58(6):1125-32. PubMed ID: 23402745
[TBL] [Abstract][Full Text] [Related]
49. [Antibiotics can ameliorate circulatory complications of liver cirrhosis].
Madsen BS; Schaffalitzky de Muckadell OB
Ugeskr Laeger; 2011 Aug; 173(35):2127-30. PubMed ID: 21884664
[TBL] [Abstract][Full Text] [Related]
50. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics.
Kumar A; Mishra SR; Sharma P; Sharma BC; Sarin SK
J Clin Gastroenterol; 2010 Apr; 44(4):294-300. PubMed ID: 19730114
[TBL] [Abstract][Full Text] [Related]
51. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
52. Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension.
Liu H; Nguyen HH; Hwang SY; Lee SS
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069125
[TBL] [Abstract][Full Text] [Related]
53. [Disorders of gut microflora in the pathogenesis of liver cirrhosis and complications of portal hypertension].
Anikina EV; Kovtun AV; Iakovenko AV; Gioeva IZ; Iakovenko ÉP; Agafonova NA; Ivanov AN; Volosheĭnikova TV; Grigor'eva IuV
Eksp Klin Gastroenterol; 2014; (12):20-3. PubMed ID: 26058107
[TBL] [Abstract][Full Text] [Related]
54. Leaky guts and lipid rafts.
Boyle EC; Finlay BB
Trends Microbiol; 2005 Dec; 13(12):560-3. PubMed ID: 16253506
[TBL] [Abstract][Full Text] [Related]
55. Mast cells trigger epithelial barrier dysfunction, bacterial translocation and postoperative ileus in a mouse model.
Snoek SA; Dhawan S; van Bree SH; Cailotto C; van Diest SA; Duarte JM; Stanisor OI; Hilbers FW; Nijhuis L; Koeman A; van den Wijngaard RM; Zuurbier CJ; Boeckxstaens GE; de Jonge WJ
Neurogastroenterol Motil; 2012 Feb; 24(2):172-84, e91. PubMed ID: 22122661
[TBL] [Abstract][Full Text] [Related]
56. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium.
Purohit V; Bode JC; Bode C; Brenner DA; Choudhry MA; Hamilton F; Kang YJ; Keshavarzian A; Rao R; Sartor RB; Swanson C; Turner JR
Alcohol; 2008 Aug; 42(5):349-61. PubMed ID: 18504085
[TBL] [Abstract][Full Text] [Related]
57. The role of bifidobacteria in gut barrier function after thermal injury in rats.
Wang Z; Xiao G; Yao Y; Guo S; Lu K; Sheng Z
J Trauma; 2006 Sep; 61(3):650-7. PubMed ID: 16967002
[TBL] [Abstract][Full Text] [Related]
58. No difference in portal and hepatic venous bacterial DNA in patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt insertion.
Mortensen C; Karlsen S; Grønbæk H; Nielsen DT; Frevert S; Clemmesen JO; Møller S; Jensen JS; Bendtsen F
Liver Int; 2013 Oct; 33(9):1309-15. PubMed ID: 23763259
[TBL] [Abstract][Full Text] [Related]
59. Lack of correlation between failure of gut barrier function and septic complications after major upper gastrointestinal surgery.
Kanwar S; Windsor AC; Welsh F; Barclay GR; Guillou PJ; Reynolds JV
Ann Surg; 2000 Jan; 231(1):88-95. PubMed ID: 10636107
[TBL] [Abstract][Full Text] [Related]
60. Is intestinal oxidative stress involved in patients with compensated liver cirrhosis?
Pijls KE; Jonkers DM; Elizalde M; Drittij-Reijnders MJ; Haenen GR; Bast A; Masclee AA; Koek GH
Ann Hepatol; 2016; 15(3):402-9. PubMed ID: 27049494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
